- From: Iker Huerga <ihuerga@linkatu.net>
- Date: Thu, 26 May 2011 16:15:17 +0200
- To: public-semweb-lifesci@w3.org
- Message-ID: <4DDE6075.5010501@linkatu.net>
Hi,
> I guess my comment would be, setting Translational Medicine as a major
> priority = ok, making it the only priority = not ok.
+1
>
>
> My personal recommendation would be to formulate the charter around
> accelerating biomedical research and promoting cross-discipline
> sharing, across the full scientific and clinical life cycle. I would
> begin by dividing into several distinct problem focused areas. I would
> lose the solution-based Task Groups and reformulate them as problem-based.
A huge +1 again
> Best
>
> Tim
>
> On May 26, 2011, at 9:31 AM, Helena Deus wrote:
>
>> Hi,
>>
>> That is a very good point, thanks Mikel and Andrea!
>> Do you have pointers to such type of data? Shall we consider an IG
>> for "basic" life sciences?
>>
>> The LS part of HCLS has indeed been gaining adepts rapidly and it may
>> make sense to reflect that in the charter.
>>
>> Cheers,
>> Lena
>>
>> 2011/5/26 Mikel Egaña Aranguren <megana@fi.upm.es
>> <mailto:megana@fi.upm.es>>
>>
>> Hi;
>>
>> I should attend the conference call but I just want to add that I
>> concur with Andrea in that the HCLS IG should consider the
>> environmental realm, since loads of new ecological/environment
>> data, with new challenges to be addressed, are waiting to be
>> represented semantically. That's precisely one of the lines we
>> are trying to open here at OEG-UPM.
>>
>> Cheers
>>
>>
>> On og., 2011.eko mairen 26a 15:08, Andrea Splendiani wrote:
>>
>> Hi,
>>
>> I see myself as more involved in the next incarnation of the
>> charter ;)
>> Unfortunately, today is a travel day and I cannot attend the
>> conference
>> call.
>>
>> I have two questions/ideas, which don't really map to the current
>> sub-groups, but just in case they ring some bell:
>>
>> -) Is the HCLS exclusively oriented on HeathCare ? (that is,
>> is the "and" in
>> Heath Care and Life Sciences IG and AND or an OR ?). Here in
>> Rothamsted, we
>> are just starting to evaluate the
>> Ecological/Agricultural/Environmental
>> connections to Life Sciences. Does this fall into the remit
>> of the IG group
>> ?
>>
>> -) Does the evaluation/ coordination of development of
>> systems which link
>> information representation and analysis side fall within the
>> remit of the IG
>> ? I think interfaces to linked data, as well as tools which
>> can analyze
>> linked data are important to improve the acceptance of
>> Semantic Web
>> technologies in the Life Sciences.
>>
>> ciao,
>> Andrea
>>
>>
>>
>>
>> Il giorno 24/mag/2011, alle ore 04.04, Eric Prud'hommeaux ha
>> scritto:
>>
>> Hi all, as some of you reallize, the charter ends at the
>> end of this
>> month. I've been polling around to see what alternative
>> formulations
>> would give us the most resources and impact. In the
>> process, I wrote
>> up some of our high-level use cases (elevator speeches)
>> to help us
>> approach the relevant parties in pharmas, health services and
>> research:<http://www.w3.org/2011/05/HCLSIGUseCases>.
>>
>> I'd like to discuss the landscape and potential
>> strategies with the
>> community. I'd particularly like to invite those who have
>> been active
>> or see themselves as being active in the next incarnation
>> of the group.
>> We'll discuss the current, fairly conservative draft charter
>> <http://www.w3.org/2011/05/HCLSIGCharter-proposal>, as
>> well as ways to
>> optimize both its message and the paths for
>> dissemination. An example
>> of a messaging alternative would be to characterize the
>> HCLS IG work
>> in terms of e.g. overarching translational medicine use
>> cases:
>> "
>> The W3C Semantic Web in Health Care and Life Sciences
>> Interest Group
>> focuses on translational medicine use cases. The group
>> will continue
>> the aggregation of cutting edge and traditional
>> scientific knowledge
>> to meet use cases for researchers, care givers, patients and
>> regulatory agencies. Due to the scope and diversity of
>> expertise
>> required to meet translational needs, the HCLS IG work
>> is broken
>> down into discrete task forces focused on particular data
>> acquisition, modeling and integration requirements:
>>
>> Terminology - identifying and integrating identifiers
>> for biological
>> processes, gross anatomy and medical procedures to promote
>> unification of domain data.
>>
>> LODD - curation of compounds, clinical trials and outcomes.
>>
>> BioRDF - modeling of biological processes and actors.
>>
>> Scientific Discourse - representation and tracking of
>> the changing
>> landscape of scientific knowledge and the driving theora and
>> experiments.
>>
>> Translational Medicine - the oversight and high-level
>> ontology that
>> connects these disciplines together in order to meet
>> immediate and
>> long term needs from pharma, health care and other
>> vested parties.
>> "
>> . Perhaps you all have some other ideas about how to tell
>> a story
>> about our work which will serve to both draw people to
>> our work and
>> our products and to help already interested parties find
>> the task
>> forces which interest them. I of course want to draw an
>> optimal
>> balance between doing work which motivates the
>> participants and
>> focusing on tasks which will accelerate education and
>> adoption by
>> important organizations.
>>
>> I'm sure you are all aware of my preference for technical
>> work, but I
>> feel that this outreach can make us all ultimately more
>> effective. I
>> will use the Thursday 26 May HCLS slot (11:00 EDT) to
>> reach out to the
>> current HCLS IG community, and whomever else you folks
>> elect to bring
>> along. Of course, I'll reserve extra teleconference
>> slots, but please
>> RSVP to me privately so I can make a guess at how many
>> ports to
>> reserve. Also, please provide what feedback you can
>> before the
>> conference. Anything we take care of before will make the
>> meeting more
>> efficient.
>>
>> Conference Details
>>
>> Date of Call: Thursday, May 26, 2011
>> Time of Call: 11:00 am Eastern Time, 4 pm UK, 5 pm CET
>> Dial-In #: +1.617.761.6200 <tel:%2B1.617.761.6200>
>> (Cambridge, MA)
>> [Note: limited access to European dial in numbers below]
>> Dial-In #: +33.4.26.46.79.03 <tel:%2B33.4.26.46.79.03>
>> (Nice, France)
>> Dial-In #: +44.203.318.0479 <tel:%2B44.203.318.0479>
>> (Bristol, UK)
>> Participant Access Code: 4257 ("HCLS")
>> IRC Channel: irc.w3.org <http://irc.w3.org/> port 6665
>> channel #HCLS (see W3C IRC page for
>> details, or see Web IRC), Quick Start: Use
>> http://www.mibbit.com/chat/?server=irc.w3.org:6665&channel=%23hcls
>> <http://www.mibbit.com/chat/?server=irc.w3.org:6665&channel=%23hcls>
>> for
>> IRC access.
>> Duration: ~1 hour
>> Convener: Eric Prud'hommeaux
>> Scribe: TBD
>>
>> HCLS IG charter/strategy discussion
>> --
>> -ericP
>>
>> Andrea Splendiani
>> Senior Bioinformatics Scientist
>> Centre for Mathematical and Computational Biology
>> +44(0)1582 763133 ext 2004
>> <tel:%2B44%280%291582%20763133%20ext%202004>
>> andrea.splendiani@bbsrc.ac.uk
>> <mailto:andrea.splendiani@bbsrc.ac.uk>
>>
>>
>>
>>
>>
>>
>>
>> --
>> Mikel Egaña Aranguren, PhD
>> http://mikeleganaaranguren.com <http://mikeleganaaranguren.com/>
>>
>> Marie Curie post-doc at Ontology Engineering Group, UPM
>> http://www.oeg-upm.net/
>>
>>
>>
>>
>>
>> --
>> Helena F. Deus
>> Post-Doctoral Researcher at DERI/NUIG
>> http://lenadeus.info/
>>
>
>
>
> The information in this e-mail is intended only for the person to whom
> it is
> addressed. If you believe this e-mail was sent to you in error and the
> e-mail
> contains patient information, please contact the Partners Compliance
> HelpLine at
> http://www.partners.org/complianceline . If the e-mail was sent to you
> in error
> but does not contain patient information, please contact the sender
> and properly
> dispose of the e-mail.
--
Iker Huerga Sánchez
Co-Founder, LINKatu
Polo de Innovación Garaia
Goiru, 1. Edificio A, 4º Piso
20500 Arrasate - Gipuzkoa
T+34 943 712 072 F+34 943 712 223
ihuerga@linkatu.net
http://www.linkatu.net
Received on Thursday, 26 May 2011 14:15:48 UTC